Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
13.02B | 10.51B | 11.32B | 7.47B | 4.67B |
Gross Profit | ||||
13.02B | 8.25B | 7.91B | 4.54B | 1.25B |
EBIT | ||||
9.91B | 5.03B | 4.13B | 2.09B | -343.00M |
EBITDA | ||||
6.87B | 5.09B | 5.79B | 3.51B | -112.00M |
Net Income Common Stockholders | ||||
2.77B | 1.38B | 2.10B | 890.00M | -2.84B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.17B | 1.69B | 2.49B | 2.71B | 1.74B |
Total Assets | ||||
26.55B | 24.01B | 21.73B | 20.52B | 18.82B |
Total Debt | ||||
9.46B | 9.60B | 9.15B | 9.14B | 9.07B |
Net Debt | ||||
8.29B | 7.91B | 6.66B | 6.43B | 7.34B |
Total Liabilities | ||||
14.55B | 14.40B | 13.11B | 13.49B | 12.49B |
Stockholders Equity | ||||
11.22B | 8.99B | 7.98B | 6.30B | 5.37B |
Cash Flow | Free Cash Flow | |||
654.00M | -166.00M | 1.22B | 1.14B | -864.00M |
Operating Cash Flow | ||||
5.60B | 3.94B | 3.94B | 2.89B | 1.33B |
Investing Cash Flow | ||||
-4.94B | -4.11B | -2.56B | -1.32B | -1.71B |
Financing Cash Flow | ||||
-1.18B | -627.00M | -1.11B | -591.00M | 568.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $19.13B | 6.47 | 21.77% | 4.01% | 3.00% | -21.63% | |
74 Outperform | $61.40B | 9.89 | 22.29% | 3.33% | 0.88% | -13.66% | |
73 Outperform | $23.91B | 6.79 | 10.23% | 9.22% | -0.93% | 115.30% | |
71 Outperform | $40.33B | 14.52 | 27.41% | 1.49% | 20.51% | 99.86% | |
68 Neutral | $37.94B | 8.31 | 12.20% | 4.55% | 31.55% | -9.00% | |
68 Neutral | $37.56B | 16.35 | 8.88% | 2.25% | -4.35% | -37.69% | |
55 Neutral | $7.03B | 3.43 | -6.29% | 6.02% | -0.15% | -51.34% |